The Cyclofluidic Integrated Discovery Platform uses microfluidic flow chemistry, on-line biochemical assays and automated drug design algorithms to make and screen potential drug molecules. “This is a key milestone for Cyclofluidic” said Chris Selway, Cyclofluidic’s Chief Technology Officer, “the majority of the drug molecules in this experiment were designed, made and tested by the platform overnight.”
*******
Contact: Elizabeth Farrant
00 44 (0)1707 358706
00 44 (0)7930 853662
elizabeth.farrant@cyclofluidic.co.uk
________________________________________